Novavax Covid-19 vaccine could get EU approval next week: Report

Novavax's Covid-19 vaccine is likely to receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the World Health Organization, a report said on Thursday.

Novavax's Covid-19 vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the World Health Organization, the Financial Times reported on Thursday, sending shares of the US drugmaker up 7 per cent.

A WHO approval could come once the health body issued its own emergency use listing or if the EMA gave it a conditional marketing authorization, the newspaper reported citing people familiar with the matter.